Haleon plc Stock price

Equities

HLN

GB00BMX86B70

Pharmaceuticals

Delayed London S.E. 12:35:10 2024-03-28 pm EDT 5-day change 1st Jan Change
333.1 GBX +0.94% Intraday chart for Haleon plc +2.81% +3.56%
Sales 2024 * 11.46B 14.48B Sales 2025 * 11.91B 15.05B Capitalization 30.42B 38.44B
Net income 2024 * 1.44B 1.83B Net income 2025 * 1.71B 2.16B EV / Sales 2024 * 3.35 x
Net Debt 2024 * 7.91B 9.99B Net Debt 2025 * 7.15B 9.03B EV / Sales 2025 * 3.15 x
P/E ratio 2024 *
20.7 x
P/E ratio 2025 *
17.7 x
Employees 25,408
Yield 2024 *
1.87%
Yield 2025 *
2.14%
Free-Float 70.97%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.94%
1 week+2.81%
Current month+0.50%
1 month+6.10%
3 months+2.97%
Current year+3.56%
More quotes
1 week
325.55
Extreme 325.55
334.35
1 month
308.37
Extreme 308.3696
335.00
Current year
308.37
Extreme 308.3696
342.15
1 year
306.80
Extreme 306.8
357.65
3 years
241.17
Extreme 241.1735
357.65
5 years
241.17
Extreme 241.1735
357.65
10 years
241.17
Extreme 241.1735
357.65
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 21-07-21
Director of Finance/CFO 52 21-11-30
Chief Tech/Sci/R&D Officer - 21-12-15
Members of the board TitleAgeSince
Director/Board Member - 22-07-17
Director/Board Member 63 22-07-17
Director/Board Member 57 22-07-17
More insiders
Date Price Change Volume
24-03-28 333.1 +0.94% 17,237,710
24-03-27 330 +1.16% 22,138,720
24-03-26 326.2 -1.20% 27,936,880
24-03-25 330.2 +0.49% 107,580,900
24-03-22 328.6 +1.40% 115,709,600

Delayed Quote London S.E., March 28, 2024 at 12:35 pm EDT

More quotes
Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows: - oral health products (27.7%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.; - Pain relief medicines (23.5%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.; - medicines for digestive health (18.9%; no. 1 worldwide): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium brands, etc.; - respiratory medicines (15.4%; no. 1 worldwide): Theraflu, Otrivin, Flonase, Contac brands, etc.; - vitamins, minerals and food supplements (14.5%; no. 1 worldwide): Centrum, Emergen-C, Caltrate brands, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa/Latin America (40.2%), North America (37.1%), and Asia/Pacific (22.7%).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
3.331 GBP
Average target price
3.608 GBP
Spread / Average Target
+8.32%
Consensus
  1. Stock
  2. Equities
  3. Stock Haleon plc - London S.E.